Abstract
A series of potent inhibitors of the sodium hydrogen exchanger-1 (NHE-1) is described. Structure-activity relationships identified the 3-methyl-4-fluoro analog 9t as a highly potent (IC50 = 0.0065 microM) and selective (NHE-2/NHE-1=1400) non-acylguanidine NHE-1 inhibitor. Pharmacokinetic studies showed that compound 9t has an oral bioavailability of 52% and a plasma half life of 1.5 h in rats. Because of its promising potency, selectivity, and a good pharmacokinetic profile, compound 9t was selected for further studies.
MeSH terms
-
Administration, Oral
-
Animals
-
Biological Availability
-
Inhibitory Concentration 50
-
Molecular Structure
-
Piperidines / chemical synthesis
-
Piperidines / chemistry*
-
Piperidines / pharmacokinetics
-
Piperidines / pharmacology*
-
Pyrimidines / chemical synthesis
-
Pyrimidines / chemistry*
-
Pyrimidines / pharmacokinetics
-
Pyrimidines / pharmacology*
-
Rats
-
Sodium-Hydrogen Exchangers / antagonists & inhibitors*
-
Sodium-Hydrogen Exchangers / metabolism
-
Structure-Activity Relationship
Substances
-
Piperidines
-
Pyrimidines
-
Sodium-Hydrogen Exchangers